Advances in technology have the potential to significantly accelerate cancer research. Technologies such as next-generation sequencing, artificial intelligence, and machine learning can provide deeper insights into cancer biology and patient data. However, the implementation of these advanced technologies requires substantial investment and expertise, which can be a limiting factor for many research institutions.
